发明人刘建华,钱学锋,沈红梅. "Method for the Synthesis of Ibrutinib Impurity 151" [P]. 中国发明专利, 专利号 CN 113411123 A, 授权公告日 2021-11-06.
Patel M V, Roberts E F, Mueller T. "A Process for Preparing High-Purity Ibrutinib Impurity 151" [P]. US Patent, US 10541247 B2, 2015-11-21.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质151 in Pharmaceutical Formulations". J. Agric. Food Chem., 2015, 1480, (8), 4426-4432.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质151 as an Impurity". Molecules, 2010, 1536, (11), 634-637.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 151 Using HRMS and NMR". Talanta, 2020, 1125, (3), 5965-5976.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 伊布替尼杂质151 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2015, 930, 924-931.